secwatch.observer — SEC 8-K summary
======================================

Issuer:     Decoy Therapeutics Inc. (DCOY)
CIK:        0001615219
Form:       8-K
Filed at:   2026-05-19T20:06:58+00:00
Accession:  0001193125-26-230749
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.08, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Decoy Therapeutics sets July 14, 2026 annual meeting; proposal deadline May 29
------------------------------------------------------------------------------

- Annual meeting of stockholders scheduled for July 14, 2026; record date May 22, 2026.
- Deadline for Rule 14a-8 stockholder proposals is close of business on May 29, 2026.
- Deadline for director nominations and other Bylaw business: May 29, 2026.
- Universal proxy rule (Rule 14a-19) notices also due by May 29, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1615219/000119312526230749/0001193125-26-230749-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1615219/000119312526230749/dcoy-20260519.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-230749

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer